At Auxier…

Jeff Auxier, President and Chief Executive Officer of Auxier Asset Management and the Auxier Focus Fund

We believe the power of compounding is the most underappreciated and valuable investment concept. A dedicated, diligent research effort is the key to seeking high compounded portfolio returns. Our unique advantage comes from the wisdom of managing portfolios in every kind of market for over 30 years. We strive to maintain an intense work ethic with the goal of mastering the principals of capital allocation.

Before investing you should carefully consider the Fund’s investment objectives, risks, charges and expenses. This and other information is in the prospectus, a copy of which may be obtained by clicking here or by calling (877) 328-9437. Please read the prospectus carefully before you invest.

The Fund may invest in value stocks, which are subject to risk that their intrinsic value may never be realized, and growth stocks, which may be susceptible to rapid price swings. Investments in mid-sized companies generally carry greater risk than is customarily associated with larger companies. Moreover, if the Fund’s portfolio is overweighed in a sector, any negative development affecting that sector will have a greater impact on the Fund than a fund that is not overweighed in that sector. An increase in interest rates typically causes a fall in the value of a debt security (Fixed-Income Securities Risk) with corresponding changes to the Fund’s value. Foreign securities are subject to additional risks including international trade, currency, political, regulatory and diplomatic risks.

In the News

The Wall Street Transcript: Looking for Strong Businesses That Are Utilizing Platforms and Data Analytics

Oct 8, 2018

We think there are too many people that have been speculating and who really don’t thoroughly understand what they own. There is a tremendous opportunity for the educated, rational investor buying stakes in individual businesses. Historically, the trend in passive capital allocation has been most popular in market peaks, like in 1999.”

The Wall Street Transcript: Investing in Biotech Companies with Free Cash Flow and a Research Focus

Dec 28, 2017

“And these are out of favor, as the economy really looks strong, but we would argue there’s still a lot of debt out there in the system, and these kinds of companies that generate enormous free cash flow and have strong leadership positions are a good value in today’s market.”

Performance Information

Growth of $10,000

Fact Sheet

AUXFX Vs S&P

This Internet site is not an offer to sell or a solicitation of an offer to buy shares of the Fund to any person in any jurisdiction in which such offer, solicitation, purchase or sale would be unlawful under the securities laws of such jurisdiction. Foreside Fund Services, LLC. Distributor (www.foreside.com) | Hosted by clnw.com